ArticleCancer medicine2026

Immune-Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex).

Karmen Iessa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.